First Foundation Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.38M Buy
3,813
+44
+1% +$15.1K 0.05% 163
2026
Q1
$1.33M Buy
3,769
+771
+26% +$275K 0.05% 162
2025
Q4
$981K Buy
2,998
+246
+9% +$78K 0.04% 178
2025
Q3
$777K Sell
2,752
-818
-23% -$237K 0.03% 195
2025
Q2
$997K Buy
3,570
+946
+36% +$268K 0.04% 190
2025
Q1
$818K Sell
2,624
-696
-21% -$206K 0.03% 183
2024
Q4
$865K Buy
3,320
+6
+0.2% +$1.78K 0.03% 183
2024
Q3
$1.07M Sell
3,314
-149
-4% -$48.7K 0.04% 169
2024
Q2
$1.08M Sell
3,463
-19
-0.5% -$5.58K 0.04% 160
2024
Q1
$990K Sell
3,482
-12
-0.3% -$3.51K 0.04% 172
2023
Q4
$1.01M Sell
3,494
-1,351
-28% -$368K 0.05% 173
2023
Q3
$1.3M Buy
4,845
+574
+13% +$143K 0.06% 163
2023
Q2
$948K Sell
4,271
-890
-17% -$207K 0.04% 180
2023
Q1
$1.25M Buy
5,161
+355
+7% +$87.1K 0.06% 156
2022
Q4
$1.26M Buy
4,806
+726
+18% +$195K 0.06% 163
2022
Q3
$920K Buy
4,080
+9
+0.2% +$2.18K 0.05% 177
2022
Q2
$991K Sell
4,071
-488
-11% -$120K 0.04% 175
2022
Q1
$1.1M Sell
4,559
-571
-11% -$131K 0.04% 183
2021
Q4
$1.15M Buy
5,130
+448
+10% +$94.6K 0.04% 188
2021
Q3
$996K Sell
4,682
-421
-8% -$96.9K 0.04% 198
2021
Q2
$1.24M Sell
5,103
-1,186
-19% -$292K 0.05% 192
2021
Q1
$1.56M Sell
6,289
-37,061
-85% -$8.84M 0.07% 156
2020
Q4
$9.97M Buy
43,350
+1,040
+2% +$240K 0.44% 49
2020
Q3
$10.8M Buy
42,310
+35,042
+482% +$8.68M 0.5% 44
2020
Q2
$1.71M Buy
7,268
+200
+3% +$45.6K 0.09% 126
2020
Q1
$1.43M Buy
7,068
+281
+4% +$61.4K 0.09% 131
2019
Q4
$1.64M Buy
6,787
+2,423
+56% +$534K 0.08% 139
2019
Q3
$845K Buy
4,364
+955
+28% +$183K 0.05% 175
2019
Q2
$628K Buy
3,409
+409
+14% +$73.2K 0.04% 204
2019
Q1
$570K Buy
3,000
+45
+2% +$8.59K 0.03% 205
2018
Q4
$575K Sell
2,955
-212
-7% -$41.4K 0.04% 236
2018
Q3
$656K Sell
3,167
-1,181
-27% -$233K 0.04% 211
2018
Q2
$803K Sell
4,348
-330
-7% -$58.4K 0.05% 187
2018
Q1
$797K Buy
4,678
+434
+10% +$79.7K 0.04% 178
2017
Q4
$738K Buy
4,244
+88
+2% +$15.6K 0.04% 196
2017
Q3
$775K Buy
4,156
+500
+14% +$88.6K 0.04% 165
2017
Q2
$630K Buy
3,656
+95
+3% +$15.5K 0.04% 183
2017
Q1
$584K Sell
3,561
-490
-12% -$81.4K 0.04% 191
2016
Q4
$592K Sell
4,051
-289
-7% -$43.5K 0.04% 179
2016
Q3
$724K Sell
4,340
-2,974
-41% -$503K 0.05% 158
2016
Q2
$1.11M Sell
7,314
-1,308
-15% -$203K 0.08% 123
2016
Q1
$1.29M Buy
8,622
+1,419
+20% +$211K 0.09% 111
2015
Q4
$1.17M Buy
7,203
+504
+8% +$79.2K 0.08% 120
2015
Q3
$927K Sell
6,699
-205
-3% -$32.3K 0.08% 121
2015
Q2
$1.06M Hold
6,904
0.08% 114
2015
Q1
$1.1M Buy
6,904
+593
+9% +$93.4K 0.09% 102
2014
Q4
$1M Buy
6,311
+600
+11% +$93.5K 0.09% 94
2014
Q3
$802K Buy
5,711
+2,435
+74% +$318K 0.08% 99
2014
Q2
$388K Sell
3,276
-1
-0% -$116 0.04% 146
2014
Q1
$404K Buy
3,277
+158
+5% +$19.2K 0.05% 125
2013
Q4
$356K Buy
3,119
+686
+28% +$78K 0.05% 130
2013
Q3
$272K Buy
2,433
+26
+1% +$2.82K 0.04% 135
2013
Q2
$237K Buy
+2,407
New +$250K 0.05% 116

Other funds holding AMGN

First Foundation Advisors's AMGN Position: Q2 2026 in Review

First Foundation Advisors increased its Amgen (AMGN) stake by 1.2% in Q2 2026, buying an estimated $15.1K and bringing the position to 3,813 shares worth $1.38M. The position accounts for 0.05% of the portfolio, ranked #163.

First Foundation Advisors first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $10.8M in Q3 2020. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • First Foundation Advisors held 3,813 shares of Amgen worth $1.38M as of Q2 2026.
  • First Foundation Advisors bought 44 Amgen shares in Q2 2026, an estimated $15.1K.
  • Amgen made up 0.05% of First Foundation Advisors's portfolio in Q2 2026, its #163 holding.
  • First Foundation Advisors first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
  • First Foundation Advisors's Amgen position peaked at $10.8M in Q3 2020.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on First Foundation Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.